東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Pharmacologic trends of heart failure

Ventura, Hector O.

FindBook

Google Book

Amazon

博客來

Pharmacologic trends of heart failure

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Pharmacologic trends of heart failure/ edited by Hector O. Ventura.
其他作者:	Ventura, Hector O.
出版者:	Cham :Springer International Publishing : : 2016.,
面頁冊數:	vii, 173 p. :ill. (some col.), digital ;24 cm.
內容註:	The Established Therapies: HF-PEF and HF-REF -- Novel Therapies for the Prevention and Management of Acute Decompensated Heart Failure -- A Comprehensive Transition of Care Plan For a Patient Admitted with Acute Decompensated Heart Failure -- Volume Assessment and Management: Medical and Device Therapies.
Contained By:	Springer eBooks
標題:	Heart failure - Chemotherapy. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-30593-6
ISBN:	9783319305936

Pharmacologic trends of heart failure
Pharmacologic trends of heart failure[electronic resource] /edited by Hector O. Ventura. - Cham :Springer International Publishing :2016. - vii, 173 p. :ill. (some col.), digital ;24 cm. - Current cardiovascular therapy. - Current cardiovascular therapy..

The Established Therapies: HF-PEF and HF-REF -- Novel Therapies for the Prevention and Management of Acute Decompensated Heart Failure -- A Comprehensive Transition of Care Plan For a Patient Admitted with Acute Decompensated Heart Failure -- Volume Assessment and Management: Medical and Device Therapies.

This volume reviews potential future therapies for heart failure, with a particular focus on ambulatory acute decompensated heart failure and the transitions from therapies in the acute setting to chronic management. Although in the developed world the incidence of and mortality from coronary heart disease and stroke have been declining over the last 15 years, heart failure is increasing in incidence, prevalence and overall mortality, despite advances in the diagnosis and management of the condition. Pharmacologic Trends of Heart Failure builds on the current understanding of pathophysiological mechanisms and insights gained from previous studies of therapeutic interventions. It is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis.

ISBN: 9783319305936

Standard No.: 10.1007/978-3-319-30593-6doiSubjects--Topical Terms:

2131368
Heart failure
--Chemotherapy.

LC Class. No.: RC685.C53

Dewey Class. No.: 616.129061

Pharmacologic trends of heart failure
LDR:02098nmm a2200325 a 4500 001 2041625
003 DE-He213
005 20161130170522.0
006 m d
007 cr nn 008maaau
008 170118s2016 gw s 0 eng d
020 $a 9783319305936 $q (electronic bk.)
020 $a 9783319305912 $q (paper)
024 7 $a 10.1007/978-3-319-30593-6 $2 doi
035 $a 978-3-319-30593-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC685.C53
072 7 $a MJD $2 bicssc
072 7 $a MED010000 $2 bisacsh
082 0 4 $a 616.129061 $2 23
090 $a RC685.C53 $b P536 2016
245 0 0 $a Pharmacologic trends of heart failure $h [electronic resource] / $c edited by Hector O. Ventura.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a vii, 173 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Current cardiovascular therapy
505 0 $a The Established Therapies: HF-PEF and HF-REF -- Novel Therapies for the Prevention and Management of Acute Decompensated Heart Failure -- A Comprehensive Transition of Care Plan For a Patient Admitted with Acute Decompensated Heart Failure -- Volume Assessment and Management: Medical and Device Therapies.
520 $a This volume reviews potential future therapies for heart failure, with a particular focus on ambulatory acute decompensated heart failure and the transitions from therapies in the acute setting to chronic management. Although in the developed world the incidence of and mortality from coronary heart disease and stroke have been declining over the last 15 years, heart failure is increasing in incidence, prevalence and overall mortality, despite advances in the diagnosis and management of the condition. Pharmacologic Trends of Heart Failure builds on the current understanding of pathophysiological mechanisms and insights gained from previous studies of therapeutic interventions. It is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis.
650 0 $a Heart failure $x Chemotherapy. $3 2131368
650 1 4 $a Medicine & Public Health. $3 890906
650 2 4 $a Cardiology. $3 861477
650 2 4 $a Pharmacotherapy. $3 1978501
700 1 $a Ventura, Hector O. $3 2200355
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Current cardiovascular therapy. $3 2057201
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-30593-6
950 $a Medicine (Springer-11650)